Menu
Sign In Pricing Add Podcast
Podcast Image

Be Well by Kelly Leveque

137. A Wholistic Approach to Pediatrics with Dr. Pejman Katiraei #WellnessWednesdays

Tue, 21 Sep 2021

Description

Dr. Pejman Katiraei has spent years using his curious mind and expertise across allopathic and holistic medicine to explore chronic conditions such as lupus, colitis, chronic fatigue syndrome, fibromyalgia, memory problems, ADHD, anxiety, and IBS in profound depth. An initial consultation with him lasts 1.5 hours, and it doesn't take long to understand why! In this episode, he explains why diseases do not "just happen," and we need to get to the root of all anomalies to truly serve children and their families. We discuss the consequences of mold toxicity, Lyme, and ADHD, the limitations of testing, and the value of a parents' gut instinct that "something is not right" with their child. Plus: the exciting technological advancements that will bring his groundbreaking work to more people around the world. You will learn about...The “wholistic” approach to medicine Limitations of testing and honoring parents’ instincts Mold symptoms and detoxificationStress, anxiety, and ADHD in children Lyme diagnosis and sensitive testing Scaling his work to help more peopleResources:Website: wholistickids.com + wholisticminds.com Instagram: @wholistickids + @wholisticmindsThanks to Sound Tea for sponsoring this episode! Use the code “bewell20” for 20% off sparkling water (without the sugar) at drinksound.comConnect with Kelly:kellyleveque.comInstagram: @bewellbykellyFacebook: www.facebook.com/bewellbykellyBe Well By Kelly is a production of Crate MediaMentioned in this episode:BWBK Protein Powder | Get $10 off your order with PODCAST10 at bewellbykelly.com.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.